How to Buy Stryker Stock
Stryker Corp
Stryker is a medical device company located in Michigan, United States, which is part of the Healthcare sector, and is traded under the ticker SYK on the NYSE exchange.
Stryker stock last closed at $346.50, down 0.05% from the previous day, and has increased 3.12% in one year. It has overperformed other stocks in the Medical Devices industry by 0.21 percentage points. Stryker stock is currently +10.02% from its 52-week low of $314.93, and -14.7% from its 52-week high of $406.19.
As of Apr 17, 2025, there are 381.58M SYK shares outstanding. The market value of SYK is $132.22B. In the past 24 hours, 1.35M SYK shares were traded.
How to Buy Stryker Stock
Wondering how to invest in Stryker stock? Here's how.
- Decide where to buy Stryker stock: You need to decide on an online brokerage, but don't worry - we've researched dozens of stock brokerages and apps to help you decide where to buy Stryker stock.
- Sign up for a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
- Deposit funds into your investment account: Choose your method of payment and add your information.
- Analyze Stryker stock: The Stryker ticker symbol is SYK. Is Stryker stock a good investment? Should you buy shares of SYK? How do SYK's underlying business fundamentals look? Do top analysts think Stryker is a good buy? Why has SYK's stock price moved recently? (Hint: Our stock research tools can help you evaluate if SYK is a good stock to buy).
- Make your SYK purchase: Decide if you will purchase SYK shares at the current market price or use a limit order to buy SYK shares at a particular price.
- Monitor your investment in SYK: Create a watchlist to monitor your investment in Stryker stock.
Step 1: Decide where to buy Stryker stock
You need an online brokerage account in order to access the NYSE market and buy SYK stock.
Our recommended brokerage: eToro
Based on our experience, eToro is the best online stock brokerage. Here's why:
- You can invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
- Access to global markets: From Tech to Financial Services, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's leading exchanges.
- Social investing: eToro has a community with more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of shares by opening an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Sign up for a brokerage account
Now that you've picked your brokerage, the next step is to fill out some personal info so you are able to buy SYK stock today.
How to Open a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal details to start a new trading account.
- Send your information by clicking the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your investment account
Now that you have finished signing up on one of the best stock trading apps, you need to deposit funds:
Check out the walkthrough below if you need help transferring funds into your new brokerage account.
Step 4: Analyze Stryker stock
Once you have chosen the best place to buy Stryker stock, it's important to evaluate their stock prior to buying, so you can comprehend the risk as well as the opportunity.
Stryker quick stats
SYK Overview
WallStreetZen was created to help part-time investors perform more in-depth fundamental analysis in less time.
You can see all of the due diligence checks on SYK's stock page.
Is SYK stock overvalued?
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge SYK's true value.
Using relative valuations ratios:
- SYK may be overvalued based on its P/E ratio of 44.08x, relative to Medical Devices industry P/E ratio of 41.14x
- SYK could be overvalued based on its P/B ratio of 6.41x, relative to Medical Devices industry P/B ratio of 3.8x
- SYK could be overvalued based on its PEG ratio of 1.29x
You can do additional valuation analysis on SYK's stock here.
A look at SYK Cashflows and Balance Sheet
Pros:
- There are more short-term assets than long-term liabilities on the SYK balance sheet.
- There are more short-term assets than short-term liabilities on the SYK balance sheet.
- SYK earnings of $3.49B is not enough to cover its interest payments.
- SYK's operating cash flow of $4.24B allows it to safely service it's debt of $13.60B.
- Total SYK debt is lower than 5 years ago, relative to shareholder equity.
Cons:
- SYK profit margin has gone down from 15.4% to 13.2% in the past year.
- SYK has a relatively high debt to equity ratio of 1.08.
Is it a good time to buy SYK stock, according to Wall Street analysts?
Out of 16 sell side analysts who track SYK, the consensus analyst rating on Stryker is a Strong Buy
Please keep in mind that analyst ratings are not stock recommendations, nor are they financial advice.
Most Recent SYK Analyst Recommendations
Shagun Singh, a bottom 14% analyst from RBC Capital maintains SYK with a buy rating and raises their SYK price target from $425.00 to $435.00, on Jan 29, 2025.
Larry Biegelsen, a top 13% analyst from Wells Fargo maintains SYK with a strong buy rating and raises their SYK price target from $427.00 to $435.00, on Jan 29, 2025.
Robbie Marcus, a top 20% analyst from JP Morgan maintains SYK with a strong buy rating and raises their SYK price target from $420.00 to $445.00, on Jan 29, 2025.
Rick Wise, a top 8% analyst from Stifel Nicolaus maintains SYK with a strong buy rating and raises their SYK price target from $400.00 to $440.00, on Jan 29, 2025.
Stifel Nicolaus's Rick Wise raised their price target on Stryker (NYSE: SYK) by 10% from $400 to $440 on 2025/01/29. The analyst maintained their Strong Buy rating on the stock.
Stryker reported its Q4 and FY 2024 earnings on 2025/01/28.
The company delivered "an excellent finish to 2024" with performance beats across multiple key metrics, Wise told investors.
The analyst added that management attributed the quarter's upbeat results to several changes in the healthcare setting that "appear to augur well for 2025."
Earnings Report
Stryker reported:
For Q4 2024:
- EPS of $4.01, which beat the Zacks Consensus Estimate of $3.87 and, by 15.9%, Q4 2023‘s $3.46.
- Revenue of $6.44B, which beat the Zacks Consensus Estimate by 1.34% and, by 10.7%, Q4 2023’s $5.82B.
For FY 2024:
- EPS of $12.19, up 15% Y/Y.
- Revenue of $22.6B, up 10.2% Y/Y.
For FY 2025, management guided:
- EPS of $13.45 to $13.70.
- Revenue growth of 8% to 9%.
Chairman & CEO Kevin A. Lobo commented: “We delivered another year of double-digit organic sales growth while continuing to expand adjusted operating margins and drive adjusted EPS growth.
“We also had many product launches and were active in M&A to further enhance our position in high-growth end markets.
“I would like to thank our teams for their efforts in delivering excellent results and positioning Stryker for sustained success in 2025 and beyond.”
Kyle Rose, a top 10% analyst from Canaccord Genuity maintains SYK with a strong buy rating and raises their SYK price target from $420.00 to $435.00, on Jan 29, 2025.
You can dig deeper into what analysts are forecasting on the Stryker stock forecast page.
Metrics for Advanced SYK Traders
SYK Growth Numbers
Last year, SYK earnings were $2.99B. During the past 5 year, SYK's earnings have gone up by 7.13% per year. This was slower than the Medical Devices industry average of 10.26%.
Last year, SYK revenue was $22.60B. In the past five year, SYK's revenue has increased by 8.71% per year. This was slower than the Medical Devices industry average of 9.92%.
Find out more about SYK's earnings and revenue performance here.
What are SYK insiders up to?
In the last year, insiders at SYK have sold more shares than they have bought.
Kevin Lobo, Chair and CEO of SYK, was the latest SYK insider to sell. They sold $8,727,184.62 worth of SYK shares on Mar 21, 2025.
Research more about who owns SYK shares here.
Does SYK stock generate passive income?
Stryker pays a dividend of 0.7%, compared to the Medical Devices industry's average dividend yield of 1.3%. If you owned $1,000 worth of SYK stock, you would have been paid $7.04 last year.
Stryker dividend payments have consistently grown over the past decade and have remained stable.
Dig into more info about Stryker dividend yield and history here.
Get opinions from other investors
One of the major reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to learn what other traders have to say.
Step 5: Make your SYK purchase
You have two main options:
- Market order: A market order is an order to buy or sell a stock at the best available price.
Market orders are mostly the best for newer investors. - Limit order: A limit order is an order to buy or sell a stock at a specific price (or better).
If you want to ensure you're buying or selling at a particular dollar amount, place a limit order.
Press the Open button and your broker will place your order.
If you require more help with investing in stocks on eToro, click the helpful video below:
Step 6: Monitor your investment in SYK
Now that you own some SYK stock, you'll want to keep up with your new stock purchase.
Put SYK on a watchlist to track your SYK stock.
SYK Feed
How to Buy Stock in Stryker
To summarize, here are the 6 steps to buy Stryker stock:
- Decide where to buy Stryker stock
- Sign up for a brokerage account
- Deposit funds into your investment account
- Analyze Stryker stock
- Make your SYK purchase
- Monitor your investment in SYK
If you require a place to buy stocks, eToro is our recommended option.
Get Started with eToro TodayIf you want to keep track of your investment in Stryker, click the button below.
Other "How To" Guides You May Enjoy
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.